Prevounce Health Releases Pregnancy-Validated Blood Pressure Monitor for Remote Patient Monitoring

News provided by

Dec 12, 2024, 08:34 ET

Pylo 900-LTE blood pressure monitor is now clinically validated and FDA cleared for use during pregnancy, addressing the ongoing crisis of gestational hypertension.

INDIANAPOLIS, Dec. 12, 2024 /PRNewswire/ -- Prevounce Health, a leading provider of remote care management software, devices, and services, announces exciting updates to its Pylo 900-LTE blood pressure monitor. The Pylo 900-LTE is now clinically validated and FDA cleared for use during pregnancy to remotely monitor for gestational hypertension, enabling the early detection of preeclampsia and the overall reduction of eclampsia in late pregnancy.

Hypertensive disorders during pregnancy (HDP) are a leading cause of fetal and maternal mortality. A recent review by the CDC found that 31% of maternal deaths during hospital delivery occurred on patients with an HPD. Remote patient monitoring (RPM) is an effective and feasible solution during pregnancy and has a demonstrated ability to improve blood pressure control in expecting mothers. With the pregnancy-validated Pylo 900-LTE and the Pylo GL1-LTE blood glucometer, as well as the Prevounce care management platform and full logistics services, Prevounce now offers the most complete solution for monitoring maternal health RPM programs.

Remote maternal monitoring also provides significant cost savings to the healthcare system and patients. Hypertensive disorders are a leading cause of complications and pre-term births. With a recent study in California calculating the median cost of premature births of $296,974 per patient, reducing such complications with remote early detection corresponds to significant reductions in cost. For the reasons highlighted above, maternal health has received increased focus from policymakers, including the Centers for Medicare & Medicaid Services (CMS).

"Clinicians and patients need new tools in the fight against fetal and maternal mortality," says Daniel Tashnek, founder and CEO of Prevounce. "Remote patient monitoring has proven to be an effective tool in managing both gestational hypertension and diabetes. We're hopeful our updated remote blood pressure monitor contributes in some small way to healthier mothers and safer pregnancies."

Learn more about the Pylo 900-LTE and explore Prevounce's family of Pylo RPM devices, including blood pressure monitors, weight scales, blood glucose meters, and pulse oximeters. Each is clinically validated, comes with 5G/4G-LTE cellular connectivity, and seamlessly transmits readings to the Prevounce remote care platform or third-party platforms via API connectivity.

About Prevounce

Prevounce delivers comprehensive cloud software, cellular-connected devices, and expert services that help healthcare organizations simplify the provision of remote patient monitoring, chronic care management, preventive care, and annual wellness visits. Through its Pylo line of RPM devices, Prevounce offers blood pressure monitors, weight scales, blood glucose meters, and pulse oximeters. Devices connect natively with the Prevounce remote care management platform and integrate with other health software via the Pylo cloud API. Learn more about the Prevounce platform and Pylo devices at prevounce.com.

Media Contact:
Casey Johnson
(818) 253-8755
[email protected]

SOURCE Prevounce Health